British Journal of Research Open Access

  • ISSN: 2394-3718
  • Journal h-index: 4
  • Journal CiteScore: 0.42
  • Journal Impact Factor: 1.64
  • Average Acceptance to publication time (5-7 days)
  • Average Article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Abstract

BLOOD CELLS MAIN TARGETS OF COROAVIRUS COVID 19 INFECTIONS

Abdulrahim Abu Jayyab  

As recent studies described Novel Coronavirus Disease (COVID-19) is commonly complicated with a hypercoagulable state and increased risk for venous thromboembolism, deep vein thrombosis (D V T) or fatal pulmonary thromboembolism (PTE ) Further, COVID-19 has been found in causing a proinflammatory and hypercoagulable state with marked increase levels seen in Lactate Dehydrogenase, Ferritin, C-reactive protein, D-Dimer, and Interleukin levels. The clinical studies have also demonstrated severe coronavirus disease 2019 (COVID-19) that is commonly developed coagulopathy, markedly elevated D-dimer, which is associated with poor prognosis of severe COVID-19. This published data indicated that the Novel Coronavirus Disease (COVID-19) caused a high incidence of hypercoagulable state among some patients that caused the sudden death